Park K - Search Results

1

Chemical Controllable Gene Drive in Drosophila.

Chae D, Lee J, Lee N, Park K, Moon SJ, Kim HH. Chae D, et al. Among authors: park k. ACS Synth Biol. 2020 Sep 18;9(9):2362-2377. doi: 10.1021/acssynbio.0c00117. Epub 2020 Aug 24. ACS Synth Biol. 2020. PMID: 32786353

2

Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.

Kim Y, Son M, Lee D, Roh H, Son H, Chae D, Bahng MY, Park K. Kim Y, et al. Among authors: park k. Clin Ther. 2013 Jul;35(7):934-40. doi: 10.1016/j.clinthera.2013.05.021. Clin Ther. 2013. PMID: 23870605 Free article. Clinical Trial.

3

Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human Beings.

Chae D, Son M, Kim Y, Son H, Park K. Chae D, et al. Among authors: park k. Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):139-148. doi: 10.1111/bcpt.12856. Epub 2017 Sep 6. Basic Clin Pharmacol Toxicol. 2018. PMID: 28805311 Free article.

4

A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy.

Chae D, Nam CM, Kim JH, Lee CK, Kim SS, Kim HS, Jung M, Cheong JH, Chung HC, Rha SY, Park K. Chae D, et al. Among authors: park k. AAPS J. 2018 May 29;20(4):72. doi: 10.1208/s12248-018-0223-8. AAPS J. 2018. PMID: 29845329 Clinical Trial.

5

Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke.

Guk J, Chae D, Son H, Yoo J, Heo JH, Park K. Guk J, et al. Among authors: park k. Br J Clin Pharmacol. 2018 Nov;84(11):2586-2599. doi: 10.1111/bcp.13715. Epub 2018 Aug 21. Br J Clin Pharmacol. 2018. PMID: 30003573 Free PMC article.

6

An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients.

Chae D, Park K. Chae D, et al. Among authors: park k. J Pharmacokinet Pharmacodyn. 2018 Oct;45(5):721-731. doi: 10.1007/s10928-018-9602-0. Epub 2018 Jul 24. J Pharmacokinet Pharmacodyn. 2018. PMID: 30043250 Clinical Trial.

7

Population PK-PD Model of Pegylated Interferon Alfa-2a in Healthy Korean Men.

Jung YS, Chae D, Park K. Jung YS, et al. Among authors: park k. J Pharm Sci. 2018 Dec;107(12):3171-3178. doi: 10.1016/j.xphs.2018.08.017. Epub 2018 Sep 1. J Pharm Sci. 2018. PMID: 30179597

8

Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly.

Guk J, Lee SG, Chae D, Kim JH, Park K. Guk J, et al. Among authors: park k. J Pharm Sci. 2019 Aug;108(8):2765-2773. doi: 10.1016/j.xphs.2019.03.022. Epub 2019 Mar 30. J Pharm Sci. 2019. PMID: 30940470

9

Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling.

Kim D, Chae D, Shim CY, Cho IJ, Hong GR, Park K, Ha JW. Kim D, et al. Among authors: park k. J Clin Med. 2019 Aug 24;8(9):1302. doi: 10.3390/jcm8091302. J Clin Med. 2019. PMID: 31450580 Free PMC article.

10

Population pharmacodynamics of cilostazol in healthy Korean subjects.

Jung YS, Chae D, Park K. Jung YS, et al. Among authors: park k. Transl Clin Pharmacol. 2018 Jun;26(2):93-98. doi: 10.12793/tcp.2018.26.2.93. Epub 2018 Jun 18. Transl Clin Pharmacol. 2018. PMID: 32055555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,441 results

Search Page

Filters